myocarditis

AMA Update 211: Novavax booster, COVID vaccines in pregnancy and boosters for kids with Sandra Fryhofer, MD

27 de octubre de 2022 casimedicos AMA Update 00:14:10 0 Comments

Sandra Fryhofer, MD, the AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP) and chair of the AMA Board of Trustees, shares news from the latest ACIP meeting, including the newest COVID booster from Novavax, more reassuring data on the safety and value of COVID vaccines for pregnant people, their infants and children, and the inclusion of COVID vaccines in the Vaccines for Children Program. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 196: Monkeypox, bivalent vaccines & updated CDC guidelines for COVID exposure with Andrea Garcia, JD, MPH

28 de septiembre de 2022 casimedicos AMA Update 00:11:29 0 Comments

AMA’s vice president of science, medicine and public health, Andrea Garcia, JD, MPH, discusses bivalent vaccine availability—including Moderna shortages and timing on boosters for kids under 12. Also covering the latest from the CDC, including: findings from a new study on patient recovery from myocarditis after receiving mRNA COVID vaccines, plus a summary of recent changes to CDC guidance on infection prevention and control recommendations for health care personnel, as well as interim guidance for managing health care personnel with SARS-CoV-2 infection or exposure to SARS-CoV-2. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 109: Sandra Fryhofer, MD, discusses updated booster recs for teens and more

11 de enero de 2022 casimedicos AMA Update 00:16:48 0 Comments

AMA CXO Todd Unger discusses news from the recent meeting of the CDC’s Advisory Committee on Immunization Practices, or ACIP, with Sandra Fryhofer, MD, AMA’s liaison to ACIP, and a member of ACIP’s COVID-19 Vaccine Workgroup. Updates include new COVID booster recommendations for teens, a shorter booster interval after a Pfizer vaccine series, new additional dose recommendations for immunocompromised children, and what you need to know about Pfizer’s new COVID vaccine formulation for adults. Also reviewing new data about preventing MIS-C (multisystem inflammatory syndrome) in children, as well as recent decision memos from the CDC director.

Read More